More blood pressure medications recalled over possible cancer concerns
<p>Mylan Pharmaceutical has issued a voluntary recall for three more blood pressure medications over possible cancer concerns.</p>
•
Dec 7, 2018, 4:01 PM
•
Updated 2,170 days ago
Share:
Mylan Pharmaceutical has issued a voluntary recall for three more blood pressure medications over possible cancer concerns.
The recalled drugs all include the medication valsartan, which has been the subject of recalls by several companies since July.
According to the drug maker, testing revealed the medication contains trace amounts of NDEA, a possible human carcinogen.
For more information, click here.
More from News 12
1:09
Students back in class following delays due to overnight water main break in Warren Township
2:41
Higher temperatures and a higher wildfire threat
0:51
Rep. Josh Gottheimer announces bid for New Jersey governor
0:19
Officials: Washington Township coach found guilty of sexually assaulting child
1:46
Photographer shares recap of the now largely contained Jennings Creek Wildfire in New Jersey
2:17
